Cart
sales@molnova.com
Neomangiferin
CAS No. 64809-67-2
Neomangiferin( Neomangiferin )
Catalog No. M15458 CAS No. 64809-67-2
Neomangiferin has beneficial effects on high fat diet-induced nonalcoholic fatty liver disease in rats.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 60 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 42 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 123 | In Stock |
|
| 50MG | 176 | In Stock |
|
| 100MG | 263 | In Stock |
|
| 200MG | 390 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNeomangiferin
-
NoteResearch use only, not for human use.
-
Brief DescriptionNeomangiferin has beneficial effects on high fat diet-induced nonalcoholic fatty liver disease in rats.
-
DescriptionNeomangiferin has beneficial effects on high fat diet-induced nonalcoholic fatty liver disease in rats. Neomangiferin and mangiferin inhibit tartrate-resistant acid phosphatase, a biochemical marker of osteoclast function and bone resorption.
-
In Vitro——
-
In Vivo——
-
SynonymsNeomangiferin
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number64809-67-2
-
Formula Weight584.483
-
Molecular FormulaC25H28O16
-
Purity>98% (HPLC)
-
SolubilitySoluble in Pyridine, Methanol, Ethanol
-
SMILESO=C1C2=C(OC3=C1C=C(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)C(O)=C3)C=C(O)C([C@H]5[C@@H]([C@H]([C@@H]([C@@H](CO)O5)O)O)O)=C2O
-
Chemical Name9H-Xanthen-9-one, 2-beta-D-glucopyranosyl-7-(beta-D-glucopyranosyloxy)-1,3,6-trihydroxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhou C,et al. Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats. Int Immunopharmacol. 2015 Mar;25(1):218-28.
molnova catalog
related products
-
Alkaline Phosphatase
Alkaline Phosphatase is an ubiquitous membrane-bound glycoprotein that catalyzes the hydrolysis of phosphate monoesters at basic pH values.
-
Vina-ginsenoside R8
Vinaginsenoside R8, a triterpenoid glycoside isolated from the rhizomes of Panacis majoris. Vinaginsenoside R8 displays activities against adenosine diphosphate (ADP)-induced platelet aggregation (IC50=25.18 μM).
-
Nemolizumab
Nemolizumab (CIM331) is a humanized monoclonal antibody targeting the human interleukin-31 receptor A, inhibiting IL-31 binding and subsequent signal transduction. It is useful for studying atopic dermatitis with pruritus.
